Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy
- 24 August 2019
- journal article
- review article
- Published by Elsevier BV in Gene
- Vol. 719, 144071
- https://doi.org/10.1016/j.gene.2019.144071
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology
This publication has 85 references indexed in Scilit:
- Selective Inhibition of Human Brain Tumor Cells through Multifunctional Quantum‐Dot‐Based siRNA DeliveryAngewandte Chemie, 2009
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008
- Tumor-targeted Delivery of siRNA by Self-assembled NanoparticlesMolecular Therapy, 2008
- Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathwayNature, 2007
- Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNAProceedings of the National Academy of Sciences of the United States of America, 2007
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- Strategies for silencing human disease using RNA interferenceNature Reviews Genetics, 2007
- Structural basis for 5′-end-specific recognition of guide RNA by the A. fulgidus Piwi proteinNature, 2005
- Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survivalCancer, 2004
- Expression profiling reveals off-target gene regulation by RNAiNature Biotechnology, 2003